Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France

Recruiting

• Conditions: Health Services for Transgender Persons; Cervical Cancer; Transgender Persons

• Registration Number: NCT05924217
• Lead Sponsor: Centre Hospitalier Universitaire de Nīmes

Brief Summary

In France, cervical cancer screening is the subject of a national screening programme organized for all asymptomatic individuals aged 25 to 65 years with a cervix. The latter contributes greatly to the prevention and early treatment of this disease, whose public health challenge is recognized worldwide.

One of the objectives of this programme is to reduce inequalities in access. Transgender men, i.e. individuals assigned to the female gender at birth but identifying with the male gender, are concerned by this screening as long as they still have a cervix, according to the same modalities as for cisgender women.

However, they are often excluded from health care, including organized screening programs. Gender change in civil status is one of the obstacles.

The provision of gynaecological care is sometimes inadequate. The lack of knowledge of health professionals and the problems of discrimination that transgender people may face reduce the chances of having equitable access.

This survey aims to explore the perception that transgender men have of cervical cancer screening and to identify the challenges they face, the obstacles and the levers to access this prevention program.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-06-12
• Study First Submitted QC: 2023-06-20
• Study First Posted: 2023-06-29
• Status Verified: 2024-01
• Study Start: 2024-01-02
• Last Update Submitted: 2024-01-30
• Last Update Posted: 2024-01-31
• Primary Completion: 2024-12-31
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

• transgender male (assigned female at birth but identifying as male)
• aged 25 to 65 years
• Having retained her cervix
• Having had sex before.

Exclusion Criteria

• Under 25 and over 65
• Not having retained his cervix
• History of cancerous lesion of the cervix

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
prevalence of transgender men who have ever been screened for cervical cancer in their lifetime	At study entry, basline (no follow-up)	answer yes to the question "Have you ever been screened for cervical cancer in your lifetime?"

Secondary Outcome Measures

Name	Time	Method
prevalence of transgender men who feel concerned about cervical cancer screening	At study entry, basline (no follow-up)	answer yes to the question "Do you feel personally involved in cervical cancer screening?"

Trial Locations

Locations (1)

CHU de Nîmes; 🇫🇷 Nîmes, France